trial

Treatment of Schizophrenia Through Internet-Based Psychoeducation

NCTId NCT00051233
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 40
Sponsored by University of Pittsburgh Medical Center
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
40
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2003-01
Primary completion
—
Eligibility
ALL · 14 Years · 55 Years

Interventions & indications

Drugs
World Wide Web-Based Psychoeducation

Sponsors

University of Pittsburgh Medical CenterLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Armando J. Rotondi, PhDPrincipal Investigator

Sites

1 total
Pittsburgh, United States

Facts & assertions

3 sourced
Enrollment
40
Phase
PHASE2
Status
COMPLETED
relationships
The graph out of here
drug
World Wide Web-Based Psychoeducation
drug
lead_sponsor
University of Pittsburgh Medical Center
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication
investigator
Armando J. Rotondi, PhD
person